IL-16 anti-HIV-1 therapy.
Viglianti
G A
GA
Parada
N A
NA
Maciaszek
J W
JW
Kornfeld
H
H
Center
D M
DM
Cruikshank
W W
WW
D019380:Anti-HIV Agents / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000821:virology; D005814:Genes, Viral / Q000187:drug effects; D005818:Genetic Engineering; D015658:HIV Infections / Q000276:immunology / Q000628:therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity*; D006801:Humans; D066298:In Vitro Techniques; D019410:Interleukin-16 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D019410:Interleukin-16